$APUS
Apimeds Pharmaceuticals US, Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Matawan, NJ
APUS chart
What traders are saying about $APUS
Latest postsApimeds Pharmaceuticals US, Inc. news
- Apimeds Pharmaceuticals US, Inc. Estimates – AMEX:APUS
TradingView ·
- MindWave Innovations Builds Four-Part Blockchain Ecosystem Around MindChain Layer 2
citybuzz - ·
- Why Is Apimeds Pharmaceuticals Stock Gaining Monday?
Yahoo Finance ·
- Inside the ICE House x Las Vegas: MindWave Innovations CEO Dr. Vin Menon
Yahoo Finance ·
Apimeds Pharmaceuticals US, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$6.0M | -$1.4M | -$777,694 |
| Diluted EPS | $-0.55 | $-0.18 | $-0.17 |
| Total assets (year end) | $164.2M | $13,057 | $422,076 |
| Cash and equivalents (year end) | $1.6M | $3,455 | $410,481 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Apimeds Pharmaceuticals US, Inc.
- Ticker
- APUS (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Matawan, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1894525
Frequently asked questions
What exchange is Apimeds Pharmaceuticals US, Inc. listed on?
Apimeds Pharmaceuticals US, Inc. trades on the NYSE under the ticker symbol APUS.
What industry is Apimeds Pharmaceuticals US, Inc. in?
Apimeds Pharmaceuticals US, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Apimeds Pharmaceuticals US, Inc. headquartered?
Apimeds Pharmaceuticals US, Inc.'s business address on file with the SEC is in Matawan, NJ.
When does Apimeds Pharmaceuticals US, Inc.'s fiscal year end?
Apimeds Pharmaceuticals US, Inc.'s fiscal year ends on December 31.